Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic arterial infusion chemotherapy combined with atezolizumab and bevacizumab for second-line treatment of recurrent liver cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer After Liver Transplantation

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Hepatic Arterial Infusion Chemotherapy

Snippet

Sponsor: Shuhong Yi | Conditions: Recurrent Liver Cancer After Liver Transplantation | Phase 2 | Status: UNKNOWN